Influenza vaccine GSK2321138A
113275
Phase 3 mab completed
Quick answer
Influenza vaccine GSK2321138A for Influenza is a Phase 3 program (mab) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Influenza
- Phase
- Phase 3
- Modality
- mab
- Status
- completed